Home Newsfeeds Regency Centers Q2 EPS $1.00 Up From $0.99 YoY

Regency Centers Q2 EPS $1.00 Up From $0.99 YoY

Regency Centers (NASDAQ:REG) reported quarterly earnings of $1.00 per share. This is a 1.01 percent increase over earnings of $0.99 per share from the same period last year.

byBenzinga Newsdesk

August 4, 2022

1 minute read

Regency Centers (NASDAQ:REG) reported quarterly earnings of $1.00 per share. This is a 1.01 percent increase over earnings of $0.99 per share from the same period last year.

News

CareCloud Unveils CirrusAI: A Generative AI Solution For Healthcare

By Benzinga Newsdesk

October 18, 9:02 AM

CirrusAI is a state-of-the-art healthcare AI platform that was first introduced in July 2023. It is powered by Google Cloud's Vertex AI and is poised to help reshape how healthcare professionals deliver patient care and

CCLD

What’s Going On With Bitcoin-Miner Iris Energy’s Stock?

By Erica Kollmann

April 1, 1:01 PM

Iris Energy reported that its 2024 expansion is now fully funded with $301 million in cash and no debt. The company said it will have 460 MW of data center capacity and 20 EH/s of Bitcoin mining capacity in 2024, with 8 EH/s currently operating and 12 EH/s additional capacity to be progressively shipped and installed over the next nine months.

IREN

News

Verve Therapeutics Announces Updates On PCSK9 Program, Company To Pause Enrollment In Heart-1 Clinical Trial Following Asymptomatic Grade 3 Transient Alt Elevation And Thrombocytopenia Seen In Sixth Participant Enrolled In 0.45 Mg/Kg Dose Cohort

By Benzinga Newsdesk

April 2, 7:08 AM

VERVE-101 is being evaluated in the Heart-1 Phase 1b clinical trial with trial endpoints of safety and tolerability as well as changes in blood PCSK9 protein and low-density lipoprotein cholesterol (LDL-C) levels in

VERV